Michael Gutknecht | Principal Scientist II
Novartis Pharma AG

Michael Gutknecht, Principal Scientist II, Novartis Pharma AG

Michael Gutknecht, PhD Immunogenicity Profiling Expert Biomedical Research Center Novartis Pharma AG

Michael Gutknecht is a Principal Scientist II at Novartis Biomedical Research in Basel, Switzerland. His expertise is focused on pre-clinical immunogenicity assessment, biologics development, translational data science, and AI-enabled predictive modeling. His work focuses on building innovative computational tools and data products that transform complex immunogenicity data into actionable insights, enabling smarter decision-making across drug discovery and development.

At the Festival of Biologics Basel 2026, Michael will join fellow leaders and experts from across the biologics ecosystem to explore the scientific and operational advances shaping discovery, development, clinical trials, manufacturing, market access and fill & finish.

Appearances:



Festival of Biologics Day 2 @ 15:50

Clinical Trials Roundtables

Translating immunogenicity risk assessment into the clinic

last published: 21/Sep/26 11:05 GMT

back to speakers

Get involved at Festival of Biologics Basel 2026

 

 

TO SPONSOR


Derek Cavanagh

Derek.Cavanagh@terrapinn.com

 

Henry Skitt
Henry.Skitt@terrapinn.com

 

TO SPEAK


Jack Beard
Jack.Beard@terrapinn.com

 

MARKETING & PRESS


Ollie McDaid

Ollie.McDaid@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.